These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37391111)

  • 1. Neurocognitive predictors of addiction-related outcomes: A systematic review of longitudinal studies.
    Christensen E; Brydevall M; Albertella L; Samarawickrama SK; Yücel M; Lee RSC
    Neurosci Biobehav Rev; 2023 Sep; 152():105295. PubMed ID: 37391111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of general cognition and executive function deficits on addiction treatment outcomes: Systematic review and discussion of neurocognitive pathways.
    Domínguez-Salas S; Díaz-Batanero C; Lozano-Rojas OM; Verdejo-García A
    Neurosci Biobehav Rev; 2016 Dec; 71():772-801. PubMed ID: 27793597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Systematic Meta-Review of Impulsivity and Compulsivity in Addictive Behaviors.
    Lee RSC; Hoppenbrouwers S; Franken I
    Neuropsychol Rev; 2019 Mar; 29(1):14-26. PubMed ID: 30927147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction: an international Delphi consensus study.
    Yücel M; Oldenhof E; Ahmed SH; Belin D; Billieux J; Bowden-Jones H; Carter A; Chamberlain SR; Clark L; Connor J; Daglish M; Dom G; Dannon P; Duka T; Fernandez-Serrano MJ; Field M; Franken I; Goldstein RZ; Gonzalez R; Goudriaan AE; Grant JE; Gullo MJ; Hester R; Hodgins DC; Le Foll B; Lee RSC; Lingford-Hughes A; Lorenzetti V; Moeller SJ; Munafò MR; Odlaug B; Potenza MN; Segrave R; Sjoerds Z; Solowij N; van den Brink W; van Holst RJ; Voon V; Wiers R; Fontenelle LF; Verdejo-Garcia A
    Addiction; 2019 Jun; 114(6):1095-1109. PubMed ID: 30133930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive correlates of medication-induced addictive behaviours in Parkinson's disease: A systematic review.
    Dawson A; Dissanayaka NN; Evans A; Verdejo-Garcia A; Chong TTJ; Frazzitta G; Ferrazzoli D; Ortelli P; Yücel M; Carter A
    Eur Neuropsychopharmacol; 2018 May; 28(5):561-578. PubMed ID: 29653742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives on neurocognitive rehabilitation as an adjunct treatment for addictive disorders: From cognitive improvement to relapse prevention.
    Rezapour T; DeVito EE; Sofuoglu M; Ekhtiari H
    Prog Brain Res; 2016; 224():345-69. PubMed ID: 26822366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Eating addiction", rather than "food addiction", better captures addictive-like eating behavior.
    Hebebrand J; Albayrak Ö; Adan R; Antel J; Dieguez C; de Jong J; Leng G; Menzies J; Mercer JG; Murphy M; van der Plasse G; Dickson SL
    Neurosci Biobehav Rev; 2014 Nov; 47():295-306. PubMed ID: 25205078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bridging the gap between the neurocognitive lab and the addiction clinic.
    Franken IHA; van de Wetering BJM
    Addict Behav; 2015 May; 44():108-114. PubMed ID: 25500167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cognitive remediation in addictions treatment].
    Pedrero-Perez EJ; Rojo-Mota G; Ruiz-Sanchez de Leon JM; Llanero-Luque M; Puerta-Garcia C
    Rev Neurol; 2011 Feb; 52(3):163-72. PubMed ID: 21287493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of neuromodulation on cognitive performance in individuals exhibiting addictive behaviour: a systematic review protocol.
    Naish KR; Vedelago L; MacKillop J; Amlung M
    Syst Rev; 2018 Jun; 7(1):90. PubMed ID: 29945682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of neurocognitive functioning, substance use variables and the DSM-5 severity scale in cocaine relapse: A prospective study.
    Lima DR; Gonçalves PD; Ometto M; Malbergier A; Amaral RA; Dos Santos B; Cavallet M; Chaim-Avancini T; Serpa MH; Ferreira LRK; Duran FLS; Zanetti MV; Nicastri S; Busatto GF; Andrade AG; Cunha PJ
    Drug Alcohol Depend; 2019 Apr; 197():255-261. PubMed ID: 30875646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sugars and Sweet Taste: Addictive or Rewarding?
    Greenberg D; St Peter JV
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addiction and brain reward and antireward pathways.
    Gardner EL
    Adv Psychosom Med; 2011; 30():22-60. PubMed ID: 21508625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and structural neuroimaging studies of delayed reward discounting in addiction: A systematic review.
    Owens MM; Syan SK; Amlung M; Beach SRH; Sweet LH; MacKillop J
    Psychol Bull; 2019 Feb; 145(2):141-164. PubMed ID: 30652907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transitionality in addiction: A "temporal continuum" hypotheses involving the aberrant motivation, the hedonic dysregulation, and the aberrant learning.
    Patrono E; Gasbarri A; Tomaz C; Nishijo H
    Med Hypotheses; 2016 Aug; 93():62-70. PubMed ID: 27372858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural systems implicated in obesity as an addictive disorder: from biological to behavioral mechanisms.
    Schulte EM; Yokum S; Potenza MN; Gearhardt AN
    Prog Brain Res; 2016; 223():329-46. PubMed ID: 26806784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neurobiology of reward and cognitive control systems and their role in incentivizing health behavior.
    Garavan H; Weierstall K
    Prev Med; 2012 Nov; 55 Suppl():S17-23. PubMed ID: 22683229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological Interventions for Decision-Making in Addiction: a Systematic Review.
    Verdejo-García A; Alcázar-Córcoles MA; Albein-Urios N
    Neuropsychol Rev; 2019 Mar; 29(1):79-92. PubMed ID: 30259388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cluster-randomized controlled trial evaluating the effects of delaying onset of adolescent substance abuse on cognitive development and addiction following a selective, personality-targeted intervention programme: the Co-Venture trial.
    O'Leary-Barrett M; Mâsse B; Pihl RO; Stewart SH; Séguin JR; Conrod PJ
    Addiction; 2017 Oct; 112(10):1871-1881. PubMed ID: 28544009
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.